Autor: |
Nagendra PB; Gynaecology Oncology Group, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia., Goad J; Gynaecology Oncology Group, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia., Nielsen S; Hunter Cancer Biobank, University of Newcastle, Callaghan, New South Wales, Australia., Rassam L; Hunter Cancer Biobank, University of Newcastle, Callaghan, New South Wales, Australia.; School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.; Hunter Area Pathology Services, Calvary Mater Newcastle, Waratah, New South Wales, Australia., Lombard JM; School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.; Department of Medical Oncology, Gynaecology Oncology, Calvary Mater Newcastle, Waratah, New South Wales, Australia., Nahar P; School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.; Gynaecology and Obstetrics, John Hunter Hospital, New Lambton Heights, New South Wales, Australia., Tanwar PS; Gynaecology Oncology Group, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia. |